Cargando…
The Clinical Utility of Molecular Imaging in COVID-19: An Update
The novel pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first discovered in Wuhan, China in late 2019 with Coronavirus disease 2019 (COVID-19) declared a global pandemic in March 2020. Primarily involving the lungs, conventional imaging with chest radiography and CT can p...
Autores principales: | Elsakka, Ahmed, Yeh, Randy, Das, Jeeban |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492514/ https://www.ncbi.nlm.nih.gov/pubmed/36243572 http://dx.doi.org/10.1053/j.semnuclmed.2022.09.002 |
Ejemplares similares
-
FDG PET/CT imaging features and clinical utility in COVID-19
por: Yeh, Randy, et al.
Publicado: (2021) -
Clinical utility of perfusion (Q)-single-photon emission computed tomography (SPECT)/CT for diagnosing pulmonary embolus (PE) in COVID-19 patients with a moderate to high pre-test probability of PE
por: Das, Jeeban P., et al.
Publicado: (2020) -
Preoperative Localization for Primary Hyperparathyroidism: A Clinical Review
por: Tay, Donovan, et al.
Publicado: (2021) -
More than Just Skin-Deep: A Review of Imaging’s Role in Guiding CAR T-Cell Therapy for Advanced Melanoma
por: Prendergast, Conor M., et al.
Publicado: (2023) -
Translating Molecules into Imaging—The Development of New PET Tracers for Patients with Melanoma
por: Vercellino, Laetitia, et al.
Publicado: (2022)